<DOC>
	<DOCNO>NCT01864005</DOCNO>
	<brief_summary>The purpose study test hypothesis onset antiplatelet effect ticagrelor rapid great clopidogrel Chinese patient ACS .</brief_summary>
	<brief_title>A Phase IV Study Onset Maintenance Antiplatelet Effect Ticagrelor Compared With Clopidogrel Chinese Patients With ACS</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Provision inform consent prior study specific procedures 2 . Female male age least 18 year 3 . Females childbearing potential must negative urine pregnancy test enrolment willing use reliable contraception 4 . Index event nonST ST segment elevation ACS . 1.Contraindication reason clopidogrel ticagrelor administer ( eg , hypersensitivity , active bleeding , moderate severe liver disease , history previous intracranial bleed , GI bleed within past 6 month , major surgery within 30 day ) 2 . Oral anticoagulation therapy GP IIb/IIIa receptor antagonist therapy within 30 day prior randomisation stop 3 . Ticagrelor clopidogrel P2Y12 inhibitor within 14 day prior randomisation 4 . Requires dialysis 5 . Nonselective nonsteroidal antiinflammatory drug ( NSAIDs ) prostacyclins ( PGI2 ) therapy stop</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Non-ST ST Elevation Acute Coronary Syndromes , Ticagrelor , Clopidogrel , Antiplatelet Effect</keyword>
</DOC>